Detalhe da pesquisa
1.
Interferon-γ controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorder.
Brain
; 147(4): 1344-1361, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931066
2.
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity.
Ann Neurol
; 94(1): 146-159, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966460
3.
IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rß1 internalization and suppress EAE.
Proc Natl Acad Sci U S A
; 117(35): 21557-21567, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817415
4.
Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis.
Glia
; 70(10): 1950-1970, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809238
5.
B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex.
J Immunol
; 201(3): 897-907, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29898965
6.
Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.
BMC Neurol
; 19(1): 116, 2019 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31176355
7.
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
JAMA
; 321(2): 165-174, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30644983
8.
Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
JAMA
; 313(3): 275-84, 2015 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25602998
9.
Cross-immunoreactivity between bacterial aquaporin-Z and human aquaporin-4: potential relevance to neuromyelitis optica.
J Immunol
; 189(9): 4602-11, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23008451
10.
Case report: Use of granulocyte-colony stimulating factor as an immunomodulatory therapy in a patient with neuromyelitis optica spectrum disorder and comorbid immunodeficiency.
Front Neurol
; 14: 1240356, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37799277
11.
Correction to: Improvements in Cognitive Processing Speed, Disability, and PatientReported Outcomes in Patients with Early RelapsingRemitting Multiple Sclerosis Treated with Natalizumab: Results of a 4year, RealWorld, OpenLabel Study.
CNS Drugs
; 37(3): 275-289, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780107
12.
Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analysis.
Neurol Ther
; 12(3): 833-848, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966440
13.
Differential Diagnosis of Tumor-like Brain Lesions.
Neurol Clin Pract
; 13(5): e200182, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664132
14.
Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.
J Neurosci
; 31(23): 8329-41, 2011 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653838
15.
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Rev Neurosci
; 23(2): 145-52, 2012 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22499673
16.
Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Int J Mol Sci
; 13(8): 10647-10659, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22949885
17.
Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis.
J Neurol
; 269(5): 2513-2526, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633525
18.
Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study.
CNS Drugs
; 36(9): 977-993, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064841
19.
Can Immune Tolerance Be Re-established in Neuromyelitis Optica?
Front Neurol
; 12: 783304, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34987468
20.
Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial.
Neurology
; 96(6): e817-e830, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33318163